Ge Healthcare

(Image: Getty/maxsattana)

GE Healthcare sets up UK biotech R&D lab

By Vassia Barba

GE Healthcare opens lab space to provide developers with access to protein and cell analysis technologies to encourage networking and partnering on R&D services.

(Image: Getty/Golubovy)

Top five stories from September

By Ben Hargreaves

The news most interesting to our readers were those featuring collaborations, whether in the production of an Ebola vaccine, biosimilars entering new markets or creating new manufacturing modalities.

Five biggest CDMO deals of the year

Five deals reshaping the CDMO industry this year

By Ben Hargreaves

The major trend so far in 2019 is the willingness to deploy capital to expand services in the cell and gene therapy sector, and we outline the five most significant deals thus far.

(Image: Getty/Graphic_photo)

Inside the Testa Bioprocess Innovation Center

By Flora Southey

Biopharma-Reporter takes you inside the recently opened Testa BioProcess Innovation Center in Uppsala, Sweden, and speaks with CEO of GE Nordics, Lotta Ljungqvist.

GE Healthcare to in-license Promosome mammalian cell lines

GE to in-license Promosome mammalian cell lines

By Zachary Brennan

GE Healthcare Life Sciences has signed a licensing agreement for Promosome’s suite of mammalian cell line development technologies, which aim to increase protein expression in mammalian cell culture. 

GE and iBio designing plant-cell based vaccine facility

GE and iBio designing plant-cell based vaccine facility

By Gareth Macdonald

GE Healthcare has started designing a vaccine manufacturing facility for an unnamed drug company, just days after expanding its collaboration with plant-cell production technology firm iBio.